TY - JOUR
T1 - Immune Responses to Pseudomonas aeruginosa Biofilm Infections
AU - Moser, Claus
AU - Jensen, Peter Østrup
AU - Thomsen, Kim
AU - Kolpen, Mette
AU - Rybtke, Morten
AU - Laulund, Anne Sofie
AU - Trøstrup, Hannah
AU - Tolker-Nielsen, Tim
N1 - Copyright © 2021 Moser, Jensen, Thomsen, Kolpen, Rybtke, Lauland, Trøstrup and Tolker-Nielsen.
PY - 2021
Y1 - 2021
N2 - Pseudomonas aeruginosa is a key pathogen of chronic infections in the lungs of cystic fibrosis patients and in patients suffering from chronic wounds of diverse etiology. In these infections the bacteria congregate in biofilms and cannot be eradicated by standard antibiotic treatment or host immune responses. The persistent biofilms induce a hyper inflammatory state that results in collateral damage of the adjacent host tissue. The host fails to eradicate the biofilm infection, resulting in hindered remodeling and healing. In the present review we describe our current understanding of innate and adaptive immune responses elicited by P. aeruginosa biofilms in cystic fibrosis lung infections and chronic wounds. This includes the mechanisms that are involved in the activation of the immune responses, as well as the effector functions, the antimicrobial components and the associated tissue destruction. The mechanisms by which the biofilms evade immune responses, and potential treatment targets of the immune response are also discussed.
AB - Pseudomonas aeruginosa is a key pathogen of chronic infections in the lungs of cystic fibrosis patients and in patients suffering from chronic wounds of diverse etiology. In these infections the bacteria congregate in biofilms and cannot be eradicated by standard antibiotic treatment or host immune responses. The persistent biofilms induce a hyper inflammatory state that results in collateral damage of the adjacent host tissue. The host fails to eradicate the biofilm infection, resulting in hindered remodeling and healing. In the present review we describe our current understanding of innate and adaptive immune responses elicited by P. aeruginosa biofilms in cystic fibrosis lung infections and chronic wounds. This includes the mechanisms that are involved in the activation of the immune responses, as well as the effector functions, the antimicrobial components and the associated tissue destruction. The mechanisms by which the biofilms evade immune responses, and potential treatment targets of the immune response are also discussed.
KW - Adaptive Immunity/drug effects
KW - Animals
KW - Anti-Bacterial Agents/therapeutic use
KW - Biofilms/drug effects
KW - Host-Pathogen Interactions
KW - Humans
KW - Immunity, Innate/drug effects
KW - Immunization, Passive
KW - Immunologic Factors/therapeutic use
KW - Pseudomonas Infections/immunology
KW - Pseudomonas aeruginosa/drug effects
UR - http://www.scopus.com/inward/record.url?scp=85102237924&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.625597
DO - 10.3389/fimmu.2021.625597
M3 - Review
C2 - 33692800
SN - 1664-3224
VL - 12
SP - 625597
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 625597
ER -